MARKET

SLS

SLS

Sellas Life Sciences Group Inc
NASDAQ
3.770
+0.460
+13.90%
After Hours: 3.850 +0.08 +2.12% 19:59 12/31 EST
OPEN
3.460
PREV CLOSE
3.310
HIGH
3.840
LOW
3.400
VOLUME
23.23M
TURNOVER
--
52 WEEK HIGH
3.990
52 WEEK LOW
0.8505
MARKET CAP
537.01M
P/E (TTM)
-13.1359
1D
5D
1M
3M
1Y
5Y
1D
Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 12/31/2025 17:40
Maxim says Sellas continues to rally with REGAL trial nearing event trigger
TipRanks · 12/31/2025 15:30
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday
Benzinga · 12/31/2025 15:12
Unusually active option classes on open December 31st
TipRanks · 12/31/2025 14:40
Largest borrow rate increases among liquid names
TipRanks · 12/31/2025 13:45
Analysts Offer Insights on Healthcare Companies: SELLAS Life Sciences Group (SLS) and Maze Therapeutics, Inc. (MAZE)
TipRanks · 12/30/2025 19:10
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 12/30/2025 17:31
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday
Benzinga · 12/30/2025 15:10
More
About SLS
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.

Webull offers Sellas Life Sciences Group Inc stock information, including NASDAQ: SLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLS stock methods without spending real money on the virtual paper trading platform.